362 related articles for article (PubMed ID: 21419125)
21. Clinical value of blocking IL-6 receptor.
Mima T; Nishimoto N
Curr Opin Rheumatol; 2009 May; 21(3):224-30. PubMed ID: 19365268
[TBL] [Abstract][Full Text] [Related]
22. Humanized antihuman IL-6 receptor antibody, tocilizumab.
Nishimoto N; Kishimoto T
Handb Exp Pharmacol; 2008; (181):151-60. PubMed ID: 18071945
[TBL] [Abstract][Full Text] [Related]
23. The biology and medical implications of interleukin-6.
Tanaka T; Kishimoto T
Cancer Immunol Res; 2014 Apr; 2(4):288-94. PubMed ID: 24764575
[TBL] [Abstract][Full Text] [Related]
24. Tocilizumab for the treatment of rheumatoid arthritis.
Tanaka T; Ogata A; Narazaki M
Expert Rev Clin Immunol; 2010 Nov; 6(6):843-54. PubMed ID: 20979549
[TBL] [Abstract][Full Text] [Related]
25. [New therapeutic strategy for autoimmune and chronic inflammatory disease based on clinical results using IL-6 blocking therapy with a humanized anti-IL-6 receptor antibody].
Yoshizaki K
Yakugaku Zasshi; 2009 Jun; 129(6):667-74. PubMed ID: 19483409
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6 as a key player in systemic inflammation and joint destruction.
Fonseca JE; Santos MJ; Canhão H; Choy E
Autoimmun Rev; 2009 Jun; 8(7):538-42. PubMed ID: 19189867
[TBL] [Abstract][Full Text] [Related]
27. Multifocal encephalopathy and autoimmune-mediated limbic encephalitis following tocilizumab therapy.
Yamaguchi Y; Furukawa K; Yamamoto T; Takahashi Y; Tanaka K; Takahashi M
Intern Med; 2014; 53(8):879-82. PubMed ID: 24739610
[TBL] [Abstract][Full Text] [Related]
28. Tocilizumab for the treatment of systemic juvenile idiopathic arthritis.
Herlin T
Expert Rev Clin Immunol; 2012 Aug; 8(6):517-25. PubMed ID: 22992145
[TBL] [Abstract][Full Text] [Related]
29. [Use of tocilizumab, an antibody against interleukin-6 receptor, for the treatment of neuromyelitis optica].
Yamamura T; Araki M
Brain Nerve; 2014 Oct; 66(10):1159-65. PubMed ID: 25296870
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling.
Jones SA; Scheller J; Rose-John S
J Clin Invest; 2011 Sep; 121(9):3375-83. PubMed ID: 21881215
[TBL] [Abstract][Full Text] [Related]
31. [Clinical benefits of anti-human IL-6 receptor antibody therapy].
Nishimoto N
Clin Calcium; 2007 Apr; 17(4):562-8. PubMed ID: 17404486
[TBL] [Abstract][Full Text] [Related]
32. Methods for treating IL-6-related diseases (US2015010554A1): a patent evaluation.
Chin YW
Expert Opin Ther Pat; 2015; 25(9):1065-8. PubMed ID: 26059273
[TBL] [Abstract][Full Text] [Related]
33. IL-6 blockers in systemic onset juvenile idiopathic arthritis.
Barone P; Pignataro R; Garozzo MT; Leonardi S
Immunotherapy; 2016; 8(1):79-87. PubMed ID: 26642378
[TBL] [Abstract][Full Text] [Related]
34. Targeting IL-6 in the treatment of inflammatory and autoimmune diseases.
Ding C; Cicuttini F; Li J; Jones G
Expert Opin Investig Drugs; 2009 Oct; 18(10):1457-66. PubMed ID: 19715447
[TBL] [Abstract][Full Text] [Related]
35. Discovery of IL-6 and Development of Anti-IL-6R Antibody.
Kishimoto T
Keio J Med; 2019; 68(4):96. PubMed ID: 31875623
[TBL] [Abstract][Full Text] [Related]
36. [IL-6 blockade].
Kaneko Y; Takeuchi T
Nihon Rinsho; 2016 Jun; 74(6):963-7. PubMed ID: 27311186
[TBL] [Abstract][Full Text] [Related]
37. Interleukin (IL-6) Immunotherapy.
Tanaka T; Narazaki M; Kishimoto T
Cold Spring Harb Perspect Biol; 2018 Aug; 10(8):. PubMed ID: 28778870
[TBL] [Abstract][Full Text] [Related]
38. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms.
Kang S; Kishimoto T
Exp Mol Med; 2021 Jul; 53(7):1116-1123. PubMed ID: 34253862
[TBL] [Abstract][Full Text] [Related]
39. [Anti-interleukin-6 receptor antibody therapy--from bedside to bench].
Nishimoto N
Nihon Rinsho Meneki Gakkai Kaishi; 2006 Oct; 29(5):289-94. PubMed ID: 17075187
[TBL] [Abstract][Full Text] [Related]
40. A bispecific antibody that targets IL-6 receptor and IL-17A for the potential therapy of patients with autoimmune and inflammatory diseases.
Lyman M; Lieuw V; Richardson R; Timmer A; Stewart C; Granger S; Woods R; Silacci M; Grabulovski D; Newman R
J Biol Chem; 2018 Jun; 293(24):9326-9334. PubMed ID: 29678878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
